Expression of the y-encoded TSPY is associated with progression of prostate cancer

Genes

Volumn 1, Issue 2, 2010, Pages 283-293

  Kido, Tatsuo ^a   Hatakeyama, Shingo ^b   Ohyama, Chikara ^b   Chris Lau, Yun Fai ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HIROSAKI UNIVERSITY   (Japan)

Author keywords

Clinical cancer; EEF1A; Latent cancer; Prostate cancer; TSPY

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; ELONGATION FACTOR 1ALPHA; PROSTATE SPECIFIC ANTIGEN; PROTEIN P63;

ADULT; AGED; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CONTROLLED STUDY; GLEASON SCORE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TESTIS SPECIFIC PROTEIN Y ENCODED GENE; TRANSCRIPTION REGULATION; Y CHROMOSOME;

EID: 79952080001     PISSN: None     EISSN: 20734425     Source Type: Journal    
DOI: 10.3390/genes1020283     Document Type: Article

References (41)

1. Arnemann, J.; Epplen, J.T.; Cooke, H.J.; Sauermann, U.; Engel, W.; Schmidtke, J. A human Ychromosomal DNA sequence expressed in testicular tissue. Nucleic Acids Res. 1987, 15, 8713-8724.
2. Zhang, J.S.; Yang-Feng, T.L.; Muller, U.; Mohandas, T.K.; de Jong, P.J.; Lau, Y.F. Molecular isolation and characterization of an expressed gene from the human Y chromosome. Hum. Mol. Genet. 1992, 1, 717-726.
3. Schnieders, F.; Dork, T.; Arnemann, J.; Vogel, T.; Werner, M.; Schmidtke, J. Testis-specific protein, Y-encoded (TSPY) expression in testicular tissues. Hum. Mol. Genet. 1996, 5, 1801-1807.
4. Kersemaekers, A.M.; Honecker, F.; Stoop, H.; Cools, M.; Molier, M.; Wolffenbuttel, K.; Bokemeyer, C.; Li, Y.; Lau, Y.F.; Oosterhuis, J.W.; Looijenga, L.H. Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY. Hum. Pathol. 2005, 36, 512-521.
5. Tsuchiya, K.; Reijo, R.; Page, D.C.; Disteche, C.M. Gonadoblastoma: molecular definition of the susceptibility region on the Y chromosome. Am. J. Hum. Genet. 1995, 57, 1400-1407.
6. Salo, P.; Kaariainen, H.; Petrovic, V.; Peltomaki, P.; Page, D.C.; de la Chapelle, A. Molecular mapping of the putative gonadoblastoma locus on the Y chromosome. Genes Chromosomes Cancer 1995, 14, 210-214.
7. Page, D.C. Hypothesis: a Y-chromosomal gene causes gonadoblastoma in dysgenetic gonads. Development 1987, Suppl. 101, 151-155.
8. Lau, Y.; Chou, P.; Iezzoni, J.; Alonzo, J.; Komuves, L. Expression of a candidate gene for the gonadoblastoma locus in gonadoblastoma and testicular seminoma. Cytogenet. Cell Genet. 2000, 91, 160-164.
9. Dubovsky, J.A.; McNeel, D.G. Inducible expression of a prostate cancer-testis antigen, SSX-2, following treatment with a DNA methylation inhibitor. Prostate 2007, 67, 1781-1790.
10. Gallagher, W.M.; Bergin, O.E.; Rafferty, M.; Kelly, Z.D.; Nolan, I.M.; Fox, E.J.; Culhane, A.C.; McArdle, L.; Fraga, M.F.; Hughes, L.; Currid, C.A.; O'Mahony, F.; Byrne, A.; Murphy, A.A.; Moss, C.; McDonnell, S.; Stallings, R.L.; Plumb, J.A.; Esteller, M.; Brown, R.; Dervan, P.A.; Easty, D.J. Multiple markers for melanoma progression regulated by DNA methylation: insights from transcriptomic studies. Carcinogenesis 2005, 26, 1856-1867.
11. Yin, Y.H.; Li, Y.Y.; Qiao, H.; Wang, H.C.; Yang, X.A.; Zhang, H.G.; Pang, X.W.; Zhang, Y.; Chen, W.F. TSPY is a cancer testis antigen expressed in human hepatocellular carcinoma. Br. J. Cancer 2005, 93, 458-463.
12. Scanlan, M.J.; Simpson, A.J.; Old, L.J. The cancer/testis genes: Review, standardization, and commentary. Cancer Immun. 2004, 4, 1.
13. Simpson, A.J.; Caballero, O.L.; Jungbluth, A.; Chen, Y.T.; Old, L.J. Cancer/testis antigens, gametogenesis and cancer. Nat. Rev. Cancer 2005, 5, 615-625.
14. Lau, Y.F.; Lau, H.W.; Komuves, L.G. Expression pattern of a gonadoblastoma candidate gene suggests a role of the Y chromosome in prostate cancer. Cytogenet. Genome Res. 2003, 101, 250-260.
15. Singh, A.P.; Bafna, S.; Chaudhary, K.; Venkatraman, G.; Smith, L.; Eudy, J.D.; Johansson, S.L.; Lin, M.F.; Batra, S.K. Genome-wide expression profiling reveals transcriptomic variation and perturbed gene networks in androgen-dependent and androgen-independent prostate cancer cells. Cancer Lett. 2008, 259, 28-38.
16. Yu, Y.P.; Landsittel, D.; Jing, L.; Nelson, J.; Ren, B.; Liu, L.; McDonald, C.; Thomas, R.; Dhir, R.; Finkelstein, S.; Michalopoulos, G.; Becich, M.; Luo, J.H. Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J. Clin. Oncol. 2004, 22, 2790-2799.
17. Stanbrough, M.; Bubley, G.J.; Ross, K.; Golub, T.R.; Rubin, M.A.; Penning, T.M.; Febbo, P.G.; Balk, S.P. Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer. Cancer Res. 2006, 66, 2815-2825.
18. Li, X.; Placencio, V.; Iturregui, J.M.; Uwamariya, C.; Sharif-Afshar, A.R.; Koyama, T.; Hayward, S.W.; Bhowmick, N.A. Prostate tumor progression is mediated by a paracrine TGF-beta/Wnt3a signaling axis. Oncogene 2008, 27, 7118-7130.
19. Waugh, D.J.; Wilson, C. The interleukin-8 pathway in cancer. Clin. Cancer Res. 2008, 14, 6735-6741.
20. Park, Y.J.; Luger, K. Structure and function of nucleosome assembly proteins. Biochem. Cell Biol. 2006, 84, 549-558.
21. Muto, S.; Senda, M.; Akai, Y.; Sato, L.; Suzuki, T.; Nagai, R.; Senda, T.; Horikoshi, M. Relationship between the structure of SET/TAF-Ibeta/INHAT and its histone chaperone activity. Proc. Natl. Acad. Sci. U. S. A. 2007, 104, 4285-4290.
22. Li, Y.; Lau, Y.F. TSPY and its X-encoded homologue interact with cyclin B but exert contrasting functions on cyclin-dependent kinase 1 activities. Oncogene 2008, 27, 6141-6150.
23. Kido, T.; Lau, Y.F. The human Y-encoded testis-specific protein interacts functionally with eukaryotic translation elongation factor eEF1A, a putative oncoprotein. Int. J. Cancer 2008, 123, 1573-1585.
24. Kahns, S.; Lund, A.; Kristensen, P.; Knudsen, C.R.; Clark, B.F.; Cavallius, J.; Merrick, W.C. The elongation factor 1 A-2 isoform from rabbit: cloning of the cDNA and characterization of the protein. Nucleic Acids Res. 1998, 26, 1884-1890.
25. Shamovsky, I.; Ivannikov, M.; Kandel, E.S.; Gershon, D.; Nudler, E. RNA-mediated response to heat shock in mammalian cells. Nature 2006, 440, 556-560.
26. Amiri, A.; Noei, F.; Jeganathan, S.; Kulkarni, G.; Pinke, D.E.; Lee, J.M. eEF1A2 activates Akt and stimulates Akt-dependent actin remodeling, invasion and migration. Oncogene 2007, 26, 3027-3040.
27. Thornton, S.; Anand, N.; Purcell, D.; Lee, J. Not just for housekeeping: protein initiation and elongation factors in cell growth and tumorigenesis. J. Mol. Med. 2003, 81, 536-548.
28. Shultz, L.D.; Sweet, H.O.; Davisson, M.T.; Coman, D.R. 'Wasted', a new mutant of the mouse with abnormalities characteristic to ataxia telangiectasia. Nature 1982, 297, 402-404.
29. Kobayashi, Y.; Yonehara, S. Novel cell death by downregulation of eEF1A1 expression in tetraploids. Cell Death Differ. 2009, 16, 139-150.
30. Chang, Y.W.; Traugh, J.A. Phosphorylation of elongation factor 1 and ribosomal protein S6 by multipotential S6 kinase and insulin stimulation of translational elongation. J. Biol. Chem. 1997, 272, 28252-28257.
31. Anand, N.; Murthy, S.; Amann, G.; Wernick, M.; Porter, L.A.; Cukier, I.H.; Collins, C.; Gray, J.W.; Diebold, J.; Demetrick, D.J.; Lee, J.M. Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer. Nat. Genet. 2002, 31, 301-305.
32. Li, R.; Wang, H.; Bekele, B.N.; Yin, Z.; Caraway, N.P.; Katz, R.L.; Stass, S.A.; Jiang, F. Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach. Oncogene 2006, 25, 2628-2635.
33. Tomlinson, V.A.; Newbery, H.J.; Wray, N.R.; Jackson, J.; Larionov, A.; Miller, W.R.; Dixon, J.M.; Abbott, C.M. Translation elongation factor eEF1A2 is a potential oncoprotein that is overexpressed in two-thirds of breast tumours. BMC Cancer 2005, 5, 113.
34. Sokoloff, M.H.; Yang, X.J.; Fumo, M.; Mhoon, D.; Brendler, C.B. Characterizing prostatic adenocarcinomas in men with a serum prostate specific antigen level of < 4.0 ng/mL. BJU Int. 2004, 93, 499-502.
35. Schroder, F.H.; van der Cruijsen-Koeter, I.; de Koning, H.J.; Vis, A.N.; Hoedemaeker, R.F.; Kranse, R. Prostate cancer detection at low prostate specific antigen. J. Urol. 2000, 163, 806-812.
36. Luo, J.; Zha, S.; Gage, W.R.; Dunn, T.A.; Hicks, J.L.; Bennett, C.J.; Ewing, C.M.; Platz, E.A.; Ferdinandusse, S.; Wanders, R.J.; Trent, J.M.; Isaacs, W.B.; De Marzo, A.M. Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer. Cancer Res. 2002, 62, 2220-2226.
37. Delongchamps, N.B.; Singh, A.; Haas, G.P. The role of prevalence in the diagnosis of prostate cancer. Cancer Control 2006, 13, 158-168.
38. Takahashi, S.; Suzuki, S.; Takahashi, S.; Inaguma, S.; Asamoto, M.; Shirai, T. Differences between latent and clinical prostate carcinomas: lower cell proliferation activity in latent cases. Prostate 2006, 66, 211-217.
39. Tan, D.; Wu, X.; Hou, M.; Lee, S.O.; Lou, W.; Wang, J.; Janarthan, B.; Nallapareddy, S.; Trump, D.L.; Gao, A.C. Interleukin-6 polymorphism is associated with more aggressive prostate cancer. J. Urol. 2005, 174, 753-756.
40. Oram, S.W.; Liu, X.X.; Lee, T.L.; Chan, W.Y.; Lau, Y.F. TSPY potentiates cell proliferation and tumorigenesis by promoting cell cycle progression in HeLa and NIH3T3 cells. BMC Cancer 2006, 6, 154.
41. Kulkarni, G.; Turbin, D.A.; Amiri, A.; Jeganathan, S.; Andrade-Navarro, M.A.; Wu, T.D.; Huntsman, D.G.; Lee, J.M. Expression of protein elongation factor eEF1A2 predicts favorable outcome in breast cancer. Breast Cancer Res. Treat. 2007, 102, 31-41.